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Mice inoculated with the murine AIDS (MAIDS)-defective virus develop severe B and T cell dysfunctions. The primary event
in the development of this disease is the infection and polyclonal expansion of the target cells of this defective virus, which
have been reported to belong to the B cell lineage. To further study the central role that these cells play in the development
of MAIDS, we attempted to establish MAIDS-defective virus-infected B cell lines in vitro. We succeeded in establishing two
cell lines, SD1 and CSTB5, from the enlarged organs of C57BL/6 mice inoculated with helper-free stocks of the MAIDS-
defective virus. Both cell lines are not transplantable in syngeneic C57BL/6 mice or in nude or CD82/2 mice and are
apparently not malignant. They both belong to the B lineage, as their immunoglobulin (Ig) genes, but not the T cell receptor
(TcR) b locus, are rearranged, suggesting that they are relatively mature B cells. However, analysis of cell surface marker
expression by FACS revealed a surface phenotype similar to that of pre-B cells (MHC I1, MHC II1, B7.21, sIgM2, sIgG2, k2,
B2202, CD52, Thy1.22, TcR2, CD32, CD42, CD82, Mac-12, 33D12). Additionally, the CSTB5 cells express CD40 and the SD1
cells express CD43. Both cell lines contain the MAIDS-defective provirus and express the expected 4.2-kb viral RNA and the
corresponding Pr60gag protein. The CSTB5 cells are nonproducer, while the SD1 cell line produces what appears to be an
endogenous MuLV. The phenotype of these cell lines is very similar to what is known about the target B cells of this virus
in vivo. These new established cell lines are likely to be useful in elucidating the mechanism(s) by which the MAIDS-defective
virus causes its target B cells to proliferate and induce T cell anergy in infected animals. © 1998 Academic Press
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INTRODUCTION
The murine acquired immunodeficiency syndrome
(MAIDS) is induced by the Duplan strain of the murine
leukemia virus (MuLV) and is characterized by lymphad-
enopathy, splenomegaly, and severe dysfunctions of
both B and T cells in susceptible mouse strains (for
reviews, see Morse et al., 1992; Jolicoeur, 1991; Mosier,
1986). This virus mixture contains nonpathogenic, repli-
cation-competent MuLVs (Chattopadhyay et al., 1991;
Legrand et al., 1982; Haas and Reshef, 1980; Guillemain
et al., 1980; Astier et al., 1982) as well as a pathogenic
defective retrovirus (Aziz et al., 1989; Chattopadhyay et
al., 1989). We have previously found that helper-free
stocks of the MAIDS-defective virus are pathogenic and
induce a lymphoproliferative disease very similar to the
disease observed after inoculation of the virus mixture
(Huang et al., 1989). This observation has been recently
confirmed with another helper-free stock (Pozsgay et al.,
1993). Infection of mice with the crude virus mixture has
been reported to lead to infection of many different cell
populations, including B cells, T cells, and macrophages
(Cheung et al., 1991; Bilello et al., 1992; Chattopadhyay et
al., 1991; Klinken et al., 1988; Kubo et al., 1992; Hitoshi et
al., 1993), as expected for replication-competent stocks.
In contrast, the use of helper-free stocks of the defective
retrovirus has allowed us to identify that cells of the B
lineage are the primary targets of the pathogenic defec-
tive virus (Huang et al., 1991). This has later been con-
firmed by analysis of purified cell subsets obtained from
mice inoculated with replication-competent stocks of the
MAIDS virus (Kim et al., 1994). It therefore appears that
infection of B cells and their subsequent proliferation is
the critical event in the initiation of the disease (Kim et
al., 1994; Simard et al., 1997; Huang et al., 1989, 1991). We
have found that the population of B cells initially infected
in vivo is present in lymph nodes draining the site of
inoculation of the virus (Simard et al., 1994). This sug-
gests that these B cells are relatively mature since im-
mature B cells are not thought to migrate in peripheral
lymph nodes. The fact that mice deficient in mature B
cells (Kim et al., 1994; Cerny et al., 1990) or with altered
conventional B cell function due to the xid mutation (Tang
et al., 1995) were resistant to the disease indeed indi-
cated the strict requirement of this cell population for
disease development and is consistent with our findings
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on the identity of the target cell population (Huang et al.,
1991). However, CD41 T cells are also required for the
development of MAIDS as shown by experiments which
depleted CD41 T cells by antibody treatment in vivo
(Yetter et al., 1988) or by use of mice genetically deficient
for CD41 T cells (Giese et al., 1994; Simard et al., 1997;
Mosier et al., 1987). It appears that CD41 T cells them-
selves do not have to be infected by the MAIDS-defective
virus for the disease to be induced (Huang et al., 1991;
and C. Simard, M. Huang, and P. Jolicoeur, unpublished
data). It is also apparent that CD41 T cells are required
at a postinfection stage to allow expansion of the in-
fected B cells and the subsequent development of full-
blown disease (Simard et al., 1997).
A major problem in studying the pathogenesis of
MAIDS has been the lack of in vitro cell lines which
mirror the in vivo phenotype of the target B cells. Klinken
et al. (1988) have established two B cell lymphomas from
mice inoculated with the LP-BM5 crude virus mixture, but
these cells are malignant, in contrast to the benign na-
ture of the infected cells found in the enlarged lymphoid
organs of MAIDS mice. The nonmalignant nature of the
MAIDS virus-infected B cells is inferred from their lack of
transplantability in syngeneic or nude mice except in
late-stage disease (Mistry and Duplan, 1973; Klinken et
al., 1988; C. Simard, S. Klein, and P. Jolicoeur unpublished
data). The attempts by some groups, including ours, to
establish cell lines in vitro led to the derivation of trans-
plantable T cell tumors or lines (Simard et al., 1995; Tang
et al., 1992; Kubo et al., 1992). We found that expansion
and transformation of T cells was a rare event in mice
inoculated with helper-free stocks of the MAIDS virus,
but occurred at a relatively high frequency when helper
viruses were present in the virus inoculum (Simard et al.,
1995). The infection and transformation of T cells in these
mice likely represents a secondary event.
In the present study we report the establishment of
two independent B cell lines which have a phenotype
similar to that of in vivo virus target cells. These estab-
lished cells do not express markers of the T, macro-
phage, or dendritic cell lineages, have rearrangements of
their immunoglobulin (Ig) loci, but not their T cell receptor
(TcR) b locus and are not malignant.
RESULTS
Establishment in vitro of B cell lines from primary
MAIDS-enlarged lymphoid organs
In order to further study the target B cell–MAIDS-
defective virus interactions which are critical in the de-
velopment of MAIDS, we attempted to establish B cell
lines in vitro from primary enlarged lymphoid organs
from mice inoculated with helper-free stocks of the
MAIDS-defective virus. The choice of helper-free stocks
was motivated by the hope of establishing nonproducer
cell lines. Two strategies were employed, the first being
simply to dissect out the enlarged organs and to place
the resulting cell suspensions in tissue culture. This
strategy led to the establishment of one cell line, CSTB5,
which has grown continuously in tissue culture for over
1 year. The CSTB5 cell line was the only B cell line that
emerged from the culture of several primary MAIDS
organs from several (over 30) mice. The difficulty in
establishing cell lines from mice inoculated with helper-
free stocks of the MAIDS virus is in line with our inability
to transplant primary MAIDS organs in syngeneic
C57BL/6 mice or in nude mice.
In order to generate additional cell lines for study, we
used an alternate approach involving transplantation of
enlarged lymphoid organs from MAIDS animals into
SCID mice depleted of NK cells by treatment with an
anti-asialo GM1 antibody. This treatment is similar to the
one used by Veronesi et al. (1994) to establish Epstein–
Barr virus (EBV)-infected human B cell lymphoma cell
lines in vitro. Of four SCID mice treated with anti-NK cell
antibody (anti-asialo GM1) which received inoculations
with primary MAIDS lymphoid tissues, two developed
ascitic growth within 3 weeks. When the ascites was
seeded to tissue culture, one of the two cultures gave
rise to a cell line, SD1, which has been cultivated in vitro
for over 1 year. This cell line was derived from a mouse
inoculated with a modified MAIDS-defective virus (Du5H/
Mo-LTR), containing the U3 LTR region of the Moloney
MuLV (Huang et al., 1991). None of the five control NK1
SCID mice injected with PBS alone and inoculated with
the same tissues developed any tumor or ascites, indi-
cating that NK cells had a significant negative effect on
the growth of these cells in vivo.
The SD1 and CSTB5 cell lines contain and express
the MAIDS-defective provirus
Our first step toward studying the phenotype of these
cells was to ascertain whether or not the cells contained
the MAIDS-defective virus. Southern blot analysis per-
formed on DNA from both cell lines showed that the
CSTB5 cells contain a unique, newly acquired provirus
(in addition to endogenous proviruses) detected by the
D30 probe (Fig. 1B, lane 2). The same integration was
observed with the 14810 cell line, a subline derived from
CSTB5 (see below), as expected (data not shown). On
the other hand, the SD1 cells harbor multiple proviruses
of the MAIDS-defective virus, as detected by the Molo-
ney U3 LTR-specific probe (Fig. 1A, lane 1). With the
same U3 LTR probe, the CSTB5 cell line was negative, as
expected, since it was derived from a mouse inoculated
with the wild-type Du5H MAIDS-defective virus (Fig. 1A,
lane 2).
Northern blot analysis was performed on these cells to
determine whether they expressed the expected 4.2-kb
MAIDS-defective viral RNA. The cells of both lines ex-
pressed the 4.2-kb viral RNA species, the CSTB5 cells at
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lower levels (Fig. 2A). Since the SD1 cell line was posi-
tive for reverse transcriptase (RT) activity, we also exam-
ined the expression of ecotropic viral RNA in the two cell
lines. Hybridization with an ecotropic MuLV env-specific
probe indicated that neither of the cell lines produced
ecotropic viral RNA (Fig. 2B). This is consistent with the
fact that the CSTB5 cell line had no RT activity (data not
shown) and implies that nonecotropic MuLV(s) is (are)
produced by the SD1 cell line. Together, these results
indicated that both cell lines were derived from primary
cells initially infected in vivo by the MAIDS defective
virus.
The SD1 and CSTB5 cell lines express the MAIDS-
defective virus Pr60gag protein
To determine whether the 4.2-kb MAIDS viral RNA
found in these cells encodes the previously character-
ized MAIDS-defective virus-specific 60-kDa gag protein
(Pr60gag), Western blotting was carried out on whole cell
protein extracts using a goat polyclonal anti-CA (p30)
MuLV antibody. This analysis revealed a 60-kDa protein
in both cell lines (Fig. 3, lanes 1 and 2). In keeping with
the RNA levels detected by Northern analysis, the CSTB5
cells produce less protein than the SD1 cells. Addition-
ally, the SD1 cells produce a full-length 65 kDa gag
protein (Fig. 3, lane 1), consistent with the fact that they
are virus producer. Curiously, the CSTB5 cell line, after
transplantation into the NK-depleted SCID mice (cell line
14810), also became RT positive (data not shown) and
now expressed both the MAIDS-defective virus Pr60gag
protein as well as a Pr65gag helper species (Fig. 3, lane
3). Passage of these cells into the SCID mice may have
activated an endogenous nonecotropic MuLV.
The SD1 and CSTB5 cell lines have rearranged Ig loci
To identify the lineage to which these MAIDS-defective
virus-infected cell lines belong, we first examined the
status of their Ig and TcR b loci by Southern blot analysis.
Both cell lines had their TcR loci in germline configura-
tion (Fig. 4A, lanes 1 and 2), and both had their Ig k locus
rearranged (Fig. 4B, lanes 1 and 2). Furthermore, the SD1
cell line also had its Ig heavy-chain locus rearranged
(Fig. 4C, lane 1). These results strongly imply that both
cell lines belong to the B cell lineage. However, it was
somewhat surprising that the CSTB5 cell line did not
have its Ig heavy locus rearranged, as one would expect
for a B cell line. It is well documented indeed that the Ig
heavy locus is the first to undergo rearrangement during
B cell development, followed by the Ig k or l loci (for
review, see Alt et al., 1987). To reconfirm that the heavy
chain in the CSTB5 cells was unrearranged, we per-
formed another Southern blot analysis on these cell line
FIG. 2. Northern blot analysis of MAIDS-defective and ecotropic viral
RNA in SD1 and CSTB5 cell lines. RNA was extracted from cells and
hybridized with the p12-specific D30 probe (A) and then stripped and
reprobed with the ecotropic MuLV env-specific probe (B). Lane 1,
CSTB5 cells; lane 2, SD1 cells; lane 3, NIH/3T3 cells infected with the
MAIDS-defective virus and ecotropic MuLV; lane 4, uninfected NIH/3T3
cells. Arrows in B, the expected full-length 8.0-kb and spliced 3.5-kb
ecotropic MuLV RNA species. (C) Hybridization of the same filter with
an 18S rRNA oligo to show equal loading of RNA.
FIG. 1. Southern blot analysis of MAIDS-defective virus DNA in the
SD1 and CSTB5 cell lines. DNA was extracted from cells or tissues,
digested with either EcoRI (A) or SacI (B), and hybridized with a
Moloney MuLV U3 LTR-specific probe (A) or with the p12-specific probe
D30 (B). (A) DNA from SD1 (lane 1) and from CSTB5 cells (lane 2). (B)
DNA from CSTB5 primary MAIDS tissue (lane 1); from CSTB5 cells (lane
2); from lymph node from another, unrelated MAIDS animal (lane 3);
normal C57BL/6 spleen (lane 4). Arrow, the unique provirus integration
observed in both the CSTB5 primary MAIDS tissue and in the estab-
lished cell line.
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DNAs with a probe for the DH region of the Ig heavy-
chain locus. The CSTB5 cell DNA gave a positive signal
with this probe (Fig. 4D, lane 2), while the SD1 cell DNA
showed no detection of the D segments (Fig. 4D, lane 1),
suggesting that only the SD1 line has undergone rear-
rangement of the Ig heavy-chain locus.
Surface phenotype of the SD1 and CSTB5 cell lines
To further characterize the identity of these two cell
lines, we studied the surface expression of a panel of
markers specific for distinct cell lineages, using flow
cytometry (Fig. 5). Both cell lines had an almost identical
phenotype to each other. Neither cell line expressed any
of the T-lineage markers tested (CD3, CD4, CD8, TcR,
Thy1.2), Mac-1, which is specific for macrophages, 33D1,
which is specific for dendritic cells, or CD5, which is
expressed on a specific subclass of B (B-1a) cells found
primarily in the peritoneum, and on T cells (Luo et al.,
1992). Both cells expressed both MHC I and MHC II as
well as the CTLA-4 ligand, B7.2 (Ward, 1996), which is in
keeping with their identity as being B cells. The CSTB5
cell line also expressed the ligand for gp39, CD40, an-
other marker of B cells (Grewal and Flavell, 1996) while
the SD1 cells expressed CD43 (Gulley et al., 1988), which
is also found on B cells. Neither cell line expressed
surface IgM, IgG, or k, which are specific to mature B
cells, suggesting that these cells are lacking some of the
characteristics of fully mature B cells. Expression of
B220, a B cell marker present in pro-B, pre-B, and mature
B cells was very low in these cells, being detected at
very low levels only occasionally. A summary of these
data is given in Table 1. Taken together, the surface
phenotype of these two cell lines indicates that they
belong to the B cell lineage and are either arrested at a
unique stage of development or are fully mature but at
the same time have sustained downregulation of some
surface markers (IgM, IgG, k, and B220) due to infection
with the MAIDS-defective virus.
The SD1 and the CSTB5 cell lines are not
transplantable
To determine whether these cells also mirror their in
vivo infected counterparts in their inability to be trans-
planted, we inoculated both cell lines (2.5 and 5.0 3 106
cells) intraperitoneally into a variety of hosts. We were
unable to transplant these cells into syngeneic C57BL/6
mice nor into nude, SCID, syngeneic CD82/2 mice or
syngeneic beige mice, which are deficient in NK cells
(Roder and Duwe, 1979). As well, transplantation of these
cell lines into C57BL/6 mice did not lead to MAIDS in the
receiving animals (observed for up to 3 months), again
confirming that it is unlikely that these cells are produc-
ing replicating ecotropic MuLV. The resistance of these
cells to transplantation is identical to that of the primary
cells infected with the MAIDS virus stocks. A summary of
the phenotypes of the SD1 and CSTB5 cell lines is given
in Table 2.
DISCUSSION
The established MAIDS cell lines are B cells
In an attempt to study the target cells of the MAIDS-
defective virus, which has been reported to belong to the
B cell lineage (Huang et al., 1991), we have established
in vitro two B cell lines from lymphoid organs of MAIDS
mice. The phenotype of these cells is that of relatively
mature B cells which have rearranged their Ig genes, but
not their T cell receptor (TcR) b gene and which express
MHC class I and II and low levels of B220, but do not
express any surface Ig, Mac-1, or any T cell markers.
Moreover, both cell lines express the costimulatory mol-
FIG. 3. Western blot analysis of viral proteins produced in the SD1
and CSTB5 cell lines. Proteins were extracted from cells and separated
by SDS–PAGE and probed with a polyclonal anti-p30 antibody. Lane 1,
SD1 cells; lane 2, CSTB5 cells; lane 3, 14810 cells (derived from CSTB5
cells); lane 4, Rat-1 cells; lane 5, v-abl-transformed 203-33 cells; lane 6,
v-abl-transformed 203-33 cells infected with helper-free MAIDS-defec-
tive virus.
FIG. 4. Southern blot analysis of rearranged immunoglobulin loci in
the SD1 and CSTB5 cell lines. DNA was extracted from cells or tissue,
digested with HindIII (A), EcoRI, and BamHI (B) or EcoRI (C and D), and
hybridized with either the TcR b (A), Ck (B), JH (C), or DH (D) probes. DNA
from SD1 cells (lane 1); from CSTB5 cells (lane 2); from normal mouse
tail DNA (lane 3). G, germline fragment.
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ecule B7.2 which is found mainly on activated B cells (for
review see Ward, 1996) and the CSTB5 and SD1 cell lines
express, respectively, CD40 and CD43, two other B cell
markers (for reviews see Grewal and Flavell, 1996;
Melchers et al., 1994). This phenotype is consistent with
that of cells belonging to the B lineage, reflecting more
closely the phenotype of a mature B cell population,
although some characteristics of fully mature B cells
(presence of surface IgM, IgG, k, and B220) are lacking.
This is consistent with our previous results showing that
MAIDS virus-infected cells are initially localized in ger-
minal centers (Simard et al., 1994), which lack pre-B
cells. Curiously, the CSTB5 cell line has its Ig k chain
rearranged in the absence of Ig heavy-chain rearrange-
ment. We have previously reported and discussed such a
phenotype in some MAIDS animals (Huang et al., 1991),
suggesting that it is unlikely to be related to the estab-
lishment of these cells in vitro, although such a scenario
is nevertheless possible. Therefore, the preponderance
of the evidence, as reiterated above, supports the notion
that these two cell lines are of the B lineage.
Two other B cell lymphoma lines derived from mice
inoculated with the LP-BM5 mixture of viruses (B6-1153
and B6-1710), which contain both ecotropic and MCF
viruses in addition to the MAIDS-defective virus, have
previously been established (Klinken et al., 1988). They
FIG. 5. Flow cytometric analysis of the SD1 and CSTB5 cell lines. SD1, CSTB5, and C57BL/6 spleen cells were labeled with the indicated antibodies
and analyzed by flow cytometry. Representative histograms are shown for several markers. The dashed line shows the level of staining of the negative
control (unlabeled or secondary antibody only). The solid line indicates the level of staining observed on the cells with the indicated antibody (directly
conjugated or primary and secondary together). Each histogram represents analysis of 5000–10,000 gated cells.
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have a phenotype similar, but not identical, to the cells
described here (Klinken et al., 1988). Indeed, neither SD1
or CSTB5 cells were transplantable into syngeneic
C57BL/6 mice, nude mice, or CD82/2mice, nor do they
express CD5, in contrast to the above-mentioned B cell
lymphoma lines.
The virological status of the SD1 and CSTB5 cells is
also interesting. Both cell lines express the MAIDS
Pr60gag protein at relatively high levels. This character-
istic is worth pointing out as we have been unable to get
high expression of Pr60gag in other B cell lines (CH33
and WEHI-231) that were infected in vitro with the
MAIDS-defective virus (S. Klein, P. Dupraz, and P. Joli-
coeur, unpublished data), suggesting that this protein
may not be tolerated well in B cells which have reached
specific stages of differentiation. In addition, the CSTB5
cells were nonproducer as documented by the absence
of RT activity in the culture medium and of Pr65gag helper
protein in Western blot analysis, strongly suggesting that
the primary cell from which this line was derived was
infected in vivo by the MAIDS-defective virus. In contrast,
the SD1 cell line, as well as the CSTB5 derivative 14810,
expressed high levels of a 65-kDa protein species, which
most likely represents a helper MuLV gag protein, even
though these cell lines were derived from mice inocu-
lated with helper-free stocks. This helper MuLV, also
detected as virions in the culture supernatant, is not
ecotropic as determined by Northern blot hybridization
with ecotropic env sequences. Moreover, this helper
MuLV does not appear to replicate in vivo since inocu-
lation of SD1 producer cells into syngeneic C57BL/6
mice did not induce MAIDS. This helper MuLV may
represent an endogenous species and may have been
acquired during passage into the SCID mice.
Why is the establishment of infected target B cells
from MAIDS mice so difficult?
The establishment of the CSTB5 MAIDS cell line in
vitro was difficult and represented a rare success after
many attempts. We had to rely upon a difficult protocol
involving passage into NK-depleted SCID mice to derive
another line, SD1. We and others have previously at-
tempted unsuccessfully to derive in vitro target B cell
lines infected with the MAIDS-defective virus (Tang et al.,
1994; Simard et al., 1995; Kubo et al., 1992). The trans-
plantation protocols used gave rise to malignant T cell
lines or tumors which were transplantable into synge-
neic C57BL/6 mice (Simard et al., 1995) or into nude mice
(Kubo et al., 1992), respectively. The third protocol gave
rise to clonal B and T cell outgrowths that were trans-
plantable into SCID mice (Tang et al., 1994). We have
rarely observed infected T cells during the course of
MAIDS using our helper-free system (Huang et al., 1991),
although up to 35% of mice inoculated with the LP-BM5
virus mixture experienced an expansion of T cells as
determined by a clonal TcR b gene rearrangement
(Klinken et al., 1988)). This bias toward obtaining T cell
tumors and lines may be due to several factors, such as
the presence of replicating MuLVs, especially in the
LP-BM5-inoculated mice, or T cells from MAIDS mice
may be more inherently transplantable than B cells. Re-
gardless of the reason for increased transplantability of T
TABLE 1
Summary of Cell Surface Marker Expression
on SD1 and CSTB5 Cell Lines
Markers SD1 CSTB5
MHC I 1 1
MHC II 1 1
B7.2 1 1
CD40 2 1
CD43 1 2
TcR 2 2
CD4 2 2
CD8 2 2
CD3 2 2
CD5 2 2
Thy1.2 2 2
Mac-1 2 2
sIgM 2 2
sIgG 2 2
k 2 2
B220 2 2/1
33D1 2 2
TABLE 2
Summary of the Characteristics of the Established MAIDS Defective Virus-Infected B Cell Lines
Cell line
IgH
rearrangement
Ck
rearrangement
TcR b
rearrangement
Virus
integration Pr60gag a Pr65gag b
RT
activityc
B cell
markers
T/Macrophage
markers Transplantabilityd
Transplantation
in NK2 micee
CSTB5 2 1 2 1 1 2 2 1 2 2 1
SD1 1 1 2 1 1 1 1 1 2 2 1
a Production of the MAIDS virus-specific 60-kDa protein.
b Production of a 65-kDa helper virus gag protein.
c Presence of reverse transcriptase activity.
d Transplantability into nu/nu, CD82/2, beige, or syngeneic C57BL/6 mice.
e Transplantability into NK-cell-depleted SCID mice.
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cells from MAIDS mice, it is clear that in our helper-free
system, the infected cell population is of the B lineage
and less than one in 10,000 T cells are infected with the
MAIDS-defective virus (C. Simard, M. Huang, and P. Joli-
coeur, unpublished data). The relation of the reported
transplantable T cells to the development of the disease
is unclear (Simard et al., 1995; Kubo et al., 1992), al-
though T cells, specifically CD41 T cells are required for
the development of MAIDS (Simard et al., 1997; Mosier et
al., 1987; Giese et al., 1994; Yetter et al., 1988).
The use of NK-depleted SCID mice was very important
in establishing the SD1 cell line since our previous at-
tempts in passing cells from MAIDS-infected tissues in
syngeneic C57BL/6, nude, and SCID mice all failed. In
addition, the CSTB5 cells were transplantable when
passed into NK-depleted SCID mice, but not into un-
manipulated SCID mice. NK cells play an important,
although poorly understood, role in mediating resistance
to intracellular pathogens and viruses as well as exhib-
iting antitumor activity (for review, see Whiteside and
Herberman, 1995). It has been reported that NK activity is
decreased during the course of MAIDS (Makino et al.,
1993) and that mice treated with IL-12, which acts directly
on NK cells, is protective in mice challenged with LP-
BM5 (Gazzinelli et al., 1994). Our results suggest that NK
cells may also play a role in mice inoculated with helper-
free stocks of the MAIDS-defective virus. The fact that
these B cell lines are not transplantable into syngeneic
C57BL/6 beige mice, which have a defect in NK cell
production (Roder and Duwe, 1979), nor into nude or
CD82/2 mice implies either that both NK cells and CD81
T cells mediate resistance or that other host factors are
involved in mediating the resistance of these cells to
transplantation.
The NK depletion protocol used to derive the SD1
MAIDS virus target cell line is similar to the one used by
Veronesi et al. (1994) to derive B-cell lymphoma lines
from human PBMC of EBV-infected patients. This proto-
col also appears to be useful in isolating target B cell
lines from mice infected with the MAIDS-defective virus.
It may be worthwhile to further attempt to increase the
efficiency of this transplantation protocol to generate
additional B cell lines infected with the MAIDS-defective
virus since very little is currently known about how the
virus reprograms these B cells and induces polyclonal T
cell anergy.
Do the established SD1 and CSTB5 cell lines
represent the in vivo target cells of the MAIDS-
defective virus?
The identity of the in vivo target cells of the MAIDS-
defective virus has been initially studied with the LP-BM5
replication-competent virus mixture (Cheung et al., 1991;
Bilello et al., 1992; Chattopadhyay et al., 1991; Hitoshi et
al., 1993; Klinken et al., 1988; Kubo et al., 1992). As
expected for a replicating virus stock, several cell pop-
ulations were found to be infected, including B cells, T
cells, and macrophages. Although the individual contri-
bution of each of these infected populations to the dis-
ease process could not be ascertained, it was, however,
clearly shown that CD41 T cells (Yetter et al., 1988;
Mosier et al., 1987; Giese et al., 1994; Simard et al., 1997)
and B cells (Tang et al., 1995; Cerny et al., 1990; Kim et al.,
1994) were essential to the development of MAIDS. The
use of helper-free stocks of the MAIDS virus was instru-
mental in establishing that the primary target cell popu-
lation of this defective virus belongs to the B cell lineage
(Huang et al., 1991). These target B cells were found to
have rearranged Ig loci and to express high levels of
cytoplasmic k mRNA and low levels of B220 (Huang et
al., 1991) and to reside in peripheral lymph nodes (Si-
mard et al., 1994). FACS analysis of cells in MAIDS-
enlarged lymph nodes has revealed that virtually all B
cells (infected and noninfected) were B220low and klow
(Simard et al., 1994; Klinman and Morse, 1989; Hartley et
al., 1989), strongly suggesting that the infected cells were
indeed B220low and klow. However, it is impossible to get
information on the MAIDS virus target B cells from other
published FACS data because they were obtained on
total cell populations present in the MAIDS lymphoid
organs and did not distinguish between infected and
noninfected cells (Simard et al., 1994; Klinman and
Morse, 1989; Hartley et al., 1989).
Although little is known about the phenotype of the in
vivo target B cells of the MAIDS-defective virus, it ap-
pears that the phenotype of the established SD1 and
CSTB5 cell lines described here is similar to what is
known about the in vivo target B cells. Both primary and
established cells have rearranged Ig loci and express no
sIgM, sIgG, or k and little or no B220. In addition, the
difficulty in transplanting the two established cell lines
reflects the phenotype of the early virus target cells in
vivo which are not transplantable (Mistry and Duplan,
1973; C. Simard, S. Klein, and P. Jolicoeur, unpublished
data), but appear to constitute a relatively benign popu-
lation of proliferating cells crucial for the development of
the disease. The MAIDS-derived B cell lymphomas es-
tablished previously (Klinken et al., 1988) are transplant-
able and appear to represent a more aggressive pheno-
type than the MAIDS target B cells which initially prolif-
erate upon infection.
The phenotype of the SD1 and CSTB5 cell lines de-
scribed here is somewhat reminiscent of the target cells
of the v-abl oncogene, which have been characterized as
pre-B cells (Rosenberg, 1982). Not only do both cell lines
have a surface phenotype similar to that of the v-abl
target cells (Chen et al., 1994; Rosenberg, 1994), but the
CSTB5 line has its k locus rearranged in the absence of
Ig heavy-chain rearrangement, a molecular change
which has also been observed in v-abl-transformed
pre-B cells (Schlissel and Baltimore, 1989). The potential
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role of c-abl in the development of MAIDS has recently
been brought into focus by our work on the effectors of
Pr60gag. We recently demonstrated that a proline-rich
domain in the p12 region of the MAIDS virus Pr60gag
associates to the SH3 domain of c-abl (Dupraz et al.,
1997). The MAIDS and the Abelson viruses may therefore
infect and activate proliferation (in the case of MAIDS) or
fully transform (in the case of v-abl) their respective
target B cell populations, apparently via some common
pathway(s).
Interestingly, CD43, which is normally found on pre-BI
cells and on plasma cells (Melchers et al., 1994), is
expressed on the SD1 cells. It has been observed that
forced expression of this protein in a B cell lymphoma
line led to enhanced survival of these cells upon serum
deprivation (Misawa et al., 1996). As well, transgenic
mice expressing CD43 in peripheral B cells develop
immunodeficiency (Ostberg et al., 1996). It will be of
interest to study the expression of this marker during the
course of MAIDS.
The presence of costimulatory molecules on the SD1
and CSTB5 cell lines may reflect the importance of B–T
cell signaling in MAIDS which has been postulated to
play a role in the development of T cell dysfunctions
which are a hallmark of MAIDS (Gilmore et al., 1993;
Makino et al. 1995; Kanagawa et al., 1995; Green et al.,
1996). Green et al. (1996) have recently reported that
antibody to gp39, the ligand for CD40, which is ex-
pressed on the CSTB5 cell line, can inhibit the develop-
ment MAIDS in C57BL/6 mice. Both cell lines described
here also express the costimulatory molecule B7.2,
which is also important in signaling T cells via CTLA-4
and CD28 (Ward, 1996). Therefore, these B cell lines may
be effective tools to further study the B–T cell interac-
tions that occur during MAIDS and the induction of T cell
anergy in vitro. Additionally, these cells are likely to be
instrumental in understanding how the Pr60gag protein
induces the proliferation of its target B cells.
MATERIALS AND METHODS
Animals and viruses
Inbred C57BL/6, nu/nu, and SCID mice were pur-
chased from Charles River Inc. (St-Constant, Quebec,
Canada). C57BL/6 Beige mice were purchased from the
Jackson Laboratory (Bar Harbor, ME). CD82/2 mice were
initially provided by Tak Mak (The Amgen Institute, To-
ronto, Ontario, Canada) and were backcrossed for six
generations onto the C57BL/6 background. Young (30–40
days old) C57BL/6 mice were inoculated with helper-free
stocks of the wild-type MAIDS-defective virus, Du5H
(Aziz et al., 1989) or with the Moloney long terminal
repeat (LTR)-tagged (Du5H/Mo-LTR) defective virus (Huang
et al., 1991). This chimeric Du5H/Mo-LTR virus was con-
structed by substituting the PstI–KpnI Du5H 39 LTR frag-
ment with the homologous fragment from Moloney MuLV.
These Moloney LTR sequences act as a molecular tag to
aid in identifying and following the virus.
Transplantation of primary MAIDS lymphoid organs
For establishment of the SD1 cell line, enlarged spleen
and lymph nodes were dissected from C57BL/6 mice
which had been inoculated with the helper-free stocks of
the Moloney LTR-tagged Du5H for 3–4 months. The or-
gan mixture was homogenized in complete RPMI me-
dium and immediately inoculated intraperitoneally, using
a 23-gauge needle, into SCID mice which were or were
not treated with 50 ml of anti-asialo GM1 antibody (Dako
Inc., Japan) to deplete their NK cells. Anti-asialo GM1
treatment began on day 21 and continued on day 0 and
every second day thereafter, for a period of 3 weeks.
Mice were monitored for the development of ascites or
other signs of cell growth. Upon evidence of cell growth,
the mice were sacrificed and the ascites were collected
and seeded into RMPI 1640 medium/10% FCS(Hyclone)/
50 3 1025 M b-mercaptoethanol and antibiotics, at ap-
proximately 106 cells/ml. The cells were split weekly. The
SD1 cell line which emerged from this protocol has been
passed for many months and survives freezing in DMSO
and the subsequent thawing.
The CSTB5 cell line was established from MAIDS
virus-infected mice and with the same protocol as sev-
eral other T cell lines (Simard et al., 1995). Briefly, en-
larged spleen and lymph nodes were aseptically re-
moved from C57BL/6 mice which had been inoculated
with helper-free stocks of the wild-type MAIDS-defective
virus 3–5 months previously. The organs were homoge-
nized in RPMI-1640 medium/10% FBS (Gibco)/50 3 1025
M b-mercaptoethanol and antibiotics and seeded at ap-
proximately 106 cells/ml. The cultures were then moni-
tored and split 1:2 twice a week. From the culture of
enlarged organs from over 30 MAIDS animals, only one
B cell line emerged.
Probes
The D30 (Aziz et al., 1989), Moloney U3M (Poirier and
Jolicoeur, 1989), ecotropic MuLV env (Chattopadhyay et
al., 1980), (Ig) JH (Alt et al., 1981; Poirier and Jolicoeur,
1989), (Ig) Ck (Lewis et al., 1982; Poirier and Jolicoeur,
1989), (Ig) DH (Alt et al., 1984), and TcR b locus (Caccia et
al. 1984; Poirier and Jolicoeur, 1989) probes have been
described previously. For use in Southern or Northern
hybridization, the probes were 32P labeled by random
priming as before (Huang et al., 1989; Poirier and Joli-
coeur, 1989).
DNA extraction and hybridization
Cellular DNAs were extracted, digested with the de-
sired restriction enzyme, electophoresed through aga-
rose, transferred to a membrane, and hybridized with the
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indicated probe, as described previously (Huang et al.,
1989; Poirier and Jolicoeur, 1989).
RNA extraction and hybridization
Total cellular RNA was isolated by the method of
Chomczynski and Sacchi (1987) and hybridized with 32P-
labeled probes, as previously described (Huang et al.,
1989).
Protein extraction and Western blotting
Proteins were extracted by lysis in RIPA buffer (150
mM NaCl, 1% NP-40, 0.5% Na desoxycholate, and 0.1%
SDS) containing protease inhibitors, followed by SDS–
PAGE and blotting with polyclonal goat-anti CA (p30)
MuLV antibodies, as described previously (Dupraz et al.,
1997).
Reverse transcriptase activity
The RT assay was performed on supernatants of cell
lines as described previously (Gorska-Flipot et al., 1992;
Huang et al., 1989).
Cell surface labeling and FACS
Cells from the established cell lines were labeled with
the antibody of choice. The fluorescein isothiocyanate
(FITC)-conjugated monoclonal antibodies 145-2C11 (mu-
rine anti CD3), GK1.5 (murine anti CD4), YTS 169.4 (mu-
rine anti CD8a), and H57-597 (murine anti-abTcR) were
purchased from Cedarlane Laboratories (Hornby, On-
tario, Canada). Biotinylated anti-CD43 (clone S7) was
purchased from PharMingen Canada (Mississauga, On-
tario). FITC-conjugated anti-murine CD5 (clone 53-7.313),
MHC I (clone Y-3) and MHC II (clone D3-137.5.7), biotin-
ylated Thy1.2 (clone 5A-8) and Mac-1 (clone M1/70.15.11),
and the anti-CD40 hybridoma (clone FGK45.5) were
kindly provided by Dr. Patrice Hugo (Clinical Research
Institute of Montreal, Montreal, Quebec). The RA3-6B2
(murine anti-B220) monoclonal antibody was a kind gift
of Dr. R. Coffman (DNAX Research Institute, Palo Alto,
CA) and was directly conjugated to FITC using the FITC
QuickTag conjugation kit (Boehringer Mannheim, Laval,
Quebec). Murine FITC-anti-m antibody and FITC–anti-rat
Ig (mouse adsorbed) was purchased from Kirkegaard
and Perry Laboratories (Gaithersburg, MD). Monoclonal
anti-murine B7.2 antibody (clone GL-1), anti-murine Ck
(clone HB58) and anti-murine dendritic cell antibody
(clone 33D1) were purchased from the American Type
Culture Collection (Bethesda, MD). The FITC-anti-rat Ig
was used as a second antibody. Cells were resuspended
at a concentration of 2 3 107/ml in PBS containing 1%
FCS and 0.1% NaN3 (wash solution) and 10
6 cells were
transferred to conical-bottom microwell wells. Cells were
then centrifuged and resuspended in a mixture of 5
mg/ml of human immunoglobulins (Sigma Chemicals,
Oakville, Ontario, Canada) and anti-Fc receptor antibody
(clone 24G2)-containing cell supernatant at room tem-
perature for 5–10 min. Cells were then washed, resus-
pended in wash solution containing the primary antibody
and incubated at 4°C for 30 min. Cells were then washed
three times and the secondary antibody was added,
incubated at 4°C for 30 min, and washed as above.
Following staining, the cells were analyzed by flow cy-
tometry using a Becton-Dickinson FACScan. Histograms
were generated using CellQuest software (Becton-Dick-
inson).
Transplantation of established cell lines
Cells (2–5 3 106) were inoculated intraperitoneally into
the desired mice in a volume of 250–500 ml PBS. The
mice were monitored for up to 1 month for evidence of
tumor formation.
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